DURECT Corporation - ROE
DRRX
Price:
$1.91
Market Cap:
$59.31M
DURECT Corporation is a biopharmaceutical enterprise dedicated to the research and development of innovative medicines, leveraging its epigenetic regulator and pharmaceutical platforms. The company provides the ALZET product range, which includes osmotic pumps and associated accessories vital for research studies conducted on mice, rats, and other laboratory animals. In its development pipeline, DURECT is advancing larsucosterol (DUR-928), an endogenous, orally administered small molecule. This compound, currently undergoing a Phase IIb clinical trial for alcohol-associated hepatitis, is designed to regulate lipid metabolism, stress and inflammatory pathways, and cellular survival and death....[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2000-09-28
Stock Exchange
NASDAQ
Ticker
DRRX
PE Ratio
[-4.44]
ROE
[13.14%]
Current Ratio
[0.98]
Dividend Yield
[0%]
Enterprise Value
[54.56M]
Dividend History
The ROE as of June 2026 (TTM) for DURECT Corporation (DRRX) is 13.14%
According to DURECT Corporation’s latest financial reports and current stock price. The company's current ROE is 13.14%. This represents a change of -112.86% compared to the average of -102.18% of the last 4 quarters.
DURECT Corporation (DRRX) Historical ROE (quarterly & annually)
How has DRRX ROE performed in the past?
The mean historical ROE of DURECT Corporation over the last ten years is -131.56%. The current 13.14% ROE has changed -109.99% with respect to the historical average. Over the past ten years (40 quarters), DRRX's ROE was at its highest in in the June 2017 quarter at 540.10%. The ROE was at its lowest in in the September 2024 quarter at -352.10%.
Average
-131.56%
Median
-108.89%
Minimum
-413.88%
Maximum
-17.20%
DURECT Corporation (DRRX) ROE by Quarter and Year
Discovering the peaks and valleys of DURECT Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 636.29%
Maximum Annual ROE = -17.20%
Minimum Annual Increase = -95.85%
Minimum Annual ROE = -413.88%
| Year | ROE | Change |
|---|---|---|
| 2024 | -91.16% | -51.21% |
| 2023 | -186.86% | 32.14% |
| 2022 | -141.42% | 125.32% |
| 2021 | -62.76% | 87.51% |
| 2020 | -33.47% | -62.82% |
| 2019 | -90.02% | -28.90% |
| 2018 | -126.61% | 636.29% |
| 2017 | -17.20% | -95.85% |
| 2016 | -413.88% | 171.80% |
| 2015 | -152.27% | 27.52% |
DURECT Corporation (DRRX) Average ROE
How has DRRX ROE performed in the past?
The current ROE of DURECT Corporation (DRRX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-139.81%
5-year avg
-103.14%
10-year avg
-131.56%
DURECT Corporation (DRRX) ROE vs. Peers
How is DRRX’s ROE compared to its peers?
DURECT Corporation’s ROE is greater than The Valens Company Inc. (-25.35%), greater than Safety Shot, Inc. (-155.04%), greater than Zynerba Pharmaceuticals, Inc. (-59.45%), less than Chicago Atlantic BDC, Inc. (11.28%), less than Heat Biologics, Inc. (28.83%), greater than Reneo Pharmaceuticals, Inc. (0%), greater than Achilles Therapeutics plc (-41.05%), greater than TCR2 Therapeutics Inc. (-71.90%), greater than Lifeward Ltd. (-243.14%), greater than Qilian International Holding Group Limited (-16.24%),
| Company | ROE | Market cap |
|---|---|---|
| -25.35% | $61.46M | |
| -155.04% | $47.41M | |
| -59.45% | $70.12M | |
| 11.28% | $233.68M | |
| 28.83% | $61.07M | |
| 0% | $60.84M | |
| -41.05% | $60.83M | |
| -71.90% | $58.11M | |
| -243.14% | $11.13M | |
| -16.24% | $38.68M |
Build a custom stock screener for DURECT Corporation (DRRX) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like DURECT Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
DURECT Corporation (DRRX) and other stocks custom spreadsheet templates
The easiest way to analyze a company like DURECT Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is DURECT Corporation's ROE?
How is the ROE calculated for DURECT Corporation (DRRX)?
What is the highest ROE for DURECT Corporation (DRRX)?
What is the 3-year average ROE for DURECT Corporation (DRRX)?
What is the 5-year average ROE for DURECT Corporation (DRRX)?
How does the current ROE for DURECT Corporation (DRRX) compare to its historical average?